Lumida
/ISPR
⌘K
Ispire Technology Inc

Ispire Technology Inc

ISPR
$1.49USD↑+4.20%+0.06 today

MARKET CAP

85.5M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$1 – $2

52W RANGE

$1
$4

AI Summary

Stalk
Buy NowMedium

Following an early Stage 1 consolidation, price has formed higher highs and higher lows above rising short-term EMAs, signaling medium-term bullish asymmetry despite a longer-term downtrend. The recent pullback held just above the 9/21 EMA zone, offering a structurally favorable entry on continued repair. Execution is now justified in small size with stops keyed to EMA support, while long-term bearish pressure remains a monitorable risk.

  • ↑Malaysia capacity rising from 6 to 80 lines, boosting margins
  • ↑Strong earnings revisions signal improved analyst expectations
  • ↓Net loss of $39.2M in FY25, gross margin at 10.7%
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Ispire Technology Inc. (NASDAQ: ISPR) specializes in precision dosing vaping technology, strategically positioned within the nicotine sector after transitioning from a prior focus on cannabis. By establishing manufacturing capabilities in Malaysia, the company aims to enhance operational sustainability while navigating complex regulatory environments. This reorientation signifies a robust adaptation amidst evolving market dynamics, emphasizing compliance and rapid innovation to capture emerging market opportunities.

Bull says

  • ↑Malaysia capacity rising from 6 to 80 lines, boosting margins
  • ↑Strong earnings revisions signal improved analyst expectations
  • ↑Cash increased to $18M, targeting cash-flow positive by H2 2026
  • ↑Age-gating tech positions ISPR for evolving FDA regulations
  • ↑Modest dividend yield potential and interest-rate sensitivity benefit

Bear says

  • ↓Net loss of $39.2M in FY25, gross margin at 10.7%
  • ↓Negative earnings yield and weak profitability factors persist
  • ↓High stock volatility and poor liquidity deter investors
  • ↓Regulatory approval timing for age-gating tech remains uncertain
  • ↓Revenue fell 29% YoY to $18.7M in Q3 2026 amid transition

Earnings Call · Q3 2025 · Mgmt. Guidance

Updated 05-29-2026neutral

Transcript signals

Bull points

  • four looking statements within the meaning of the Private Securities Litigation Reform Act of 1995
  • during the quarter, we were able to reduce our account receivable by approximately $7.3 million from the previous quarter to approximately $60.4 million. This includes a reduction in the underlining account receivable balance of approximately $2.6 million, reverting the trend we have seen with the increase in account receivable during previous quarters.
  • We expect to continue making more progress on reducing our account receivable in the coming quarters as we focus on higher quality and the larger customers with improved payment terms.

Bear points

  • For the third quarter of fiscal 2025, total revenue decreased to 26.2 million, representing a change of 12.7% or 3.8 million compared to 30 million in the same period last year.
  • Revenue from North America of approximately 8.8 million in Q3 fiscal 2025 represented a decline of 3.6 million or 28.9% compared to 12.4 million for the third quarter in fiscal 2024.
  • Asia-Pacific revenues of approximately 3 million represented a decline of 0.8 million or 21.4% compared to 3.8 million in the third quarter of last fiscal year.
Read full transcript analysis ›